Sangamo Therapeutics Announces Participation at Jefferies Healthcare Conference
Sangamo Therapeutics, Inc. (Nasdaq: SGMO) announced management will participate in a fireside chat at the Jefferies Healthcare Conference on June 4th at 11am ET. The session will be available via live webcast on the Sangamo Therapeutics website and will also be accessible after the event. Sangamo is dedicated to advancing genomic medicines, including gene therapy and genome engineering, with aims to transform patient care. For additional details, visit Sangamo's official website.
- Participation in a notable event like the Jefferies Healthcare Conference highlights Sangamo's industry relevance.
- The live webcast allows for broader investor engagement and transparency.
- None.
Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 4th at 11am Eastern Time.
The virtual session will be webcast live and may be accessed on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo Therapeutics website after the event.
About Sangamo Therapeutics
Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, cell therapy, and genome engineering. For more information about Sangamo, visit www.sangamo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210521005024/en/
FAQ
When is Sangamo's management participating in the Jefferies Healthcare Conference?
Where can I access the webcast of Sangamo's presentation?
What is Sangamo Therapeutics focused on?